111 related articles for article (PubMed ID: 7764741)
1. Problems with serum-free production of antithrombin III regarding proteolytic activity and product quality.
Teige M; Weidemann R; Kretzmer G
J Biotechnol; 1994 Apr; 34(1):101-5. PubMed ID: 7764741
[TBL] [Abstract][Full Text] [Related]
2. Repeated batch cultivation of rBHK cells on Cytodex 3 microcarriers: antithrombin III, amino acid, and fatty acid metabolic quotients.
Schmid G; Zilg H; Johannsen R
Appl Microbiol Biotechnol; 1992 Dec; 38(3):328-33. PubMed ID: 1283684
[TBL] [Abstract][Full Text] [Related]
3. Production of human antithrombin-III in a serum-free culture of CHO cells.
Yamauchi T; Asakura E; Amatsuji Y; Uno S; Furuta R; Tujikawa M; Tanabe T
Biosci Biotechnol Biochem; 1992 Apr; 56(4):600-4. PubMed ID: 1368211
[TBL] [Abstract][Full Text] [Related]
4. Serum- and protein-free media formulations for the Chinese hamster ovary cell line DUKXB11.
Schröder M; Matischak K; Friedl P
J Biotechnol; 2004 Mar; 108(3):279-92. PubMed ID: 15006429
[TBL] [Abstract][Full Text] [Related]
5. Comparison of a production process in a membrane-aerated stirred tank and up to 1000-L airlift bioreactors using BHK-21 cells and chemically defined protein-free medium.
Hesse F; Ebel M; Konisch N; Sterlinski R; Kessler W; Wagner R
Biotechnol Prog; 2003; 19(3):833-43. PubMed ID: 12790647
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the new serum-free medium (MDSS2) for the production of different biologicals: use of various cell lines.
Merten OW; Kierulff JV; Castignolles N; Perrin P
Cytotechnology; 1994; 14(1):47-59. PubMed ID: 7765112
[TBL] [Abstract][Full Text] [Related]
7. Sialidase activity in culture fluid of Chinese hamster ovary cells during batch culture and its effects on recombinant human antithrombin III integrity.
Munzert E; Mthing J; Büntemeyer H; Lehmann J
Biotechnol Prog; 1996; 12(4):559-63. PubMed ID: 8987482
[TBL] [Abstract][Full Text] [Related]
8. Expression of human antithrombin III in Saccharomyces cerevisiae and Schizosaccharomyces pombe.
Bröker M; Ragg H; Karges HE
Biochim Biophys Acta; 1987 Apr; 908(3):203-13. PubMed ID: 3032260
[TBL] [Abstract][Full Text] [Related]
9. Effect of free fatty acids and phospholipids on growth of and product formation by recombinant baby hamster kidney (rBHK) and Chinese hamster ovary (rCHO) cells in culture.
Schmid G; Zilg H; Eberhard U; Johannsen R
J Biotechnol; 1991 Feb; 17(2):155-67. PubMed ID: 1366984
[TBL] [Abstract][Full Text] [Related]
10. Control of the cultivation process of antithrombin III and its characterization by capillary electrophoresis.
Reif OW; Freitag R
J Chromatogr A; 1994 Oct; 680(2):383-94. PubMed ID: 7981822
[TBL] [Abstract][Full Text] [Related]
11. Development of a fed-batch culture process for enhanced production of recombinant human antithrombin by Chinese hamster ovary cells.
Kuwae S; Ohda T; Tamashima H; Miki H; Kobayashi K
J Biosci Bioeng; 2005 Nov; 100(5):502-10. PubMed ID: 16384788
[TBL] [Abstract][Full Text] [Related]
12. Yeast hydrolysate as a low-cost additive to serum-free medium for the production of human thrombopoietin in suspension cultures of Chinese hamster ovary cells.
Sung YH; Lim SW; Chung JY; Lee GM
Appl Microbiol Biotechnol; 2004 Feb; 63(5):527-36. PubMed ID: 12856163
[TBL] [Abstract][Full Text] [Related]
13. Expression of human antithrombin III in the cellular slime mould Dictyostelium discoideum.
Dingermann T; Troidl EM; Bröker M; Nerke K
Appl Microbiol Biotechnol; 1991 Jul; 35(4):496-503. PubMed ID: 1367393
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the proteolytic potential of in vitro-cultivated hybridoma and recombinant mammalian cells.
Kratje RB; Lind W; Wagner R
J Biotechnol; 1994 Feb; 32(2):107-25. PubMed ID: 7764558
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of GADD34 enhances production of recombinant human antithrombin III in Chinese hamster ovary cells.
Omasa T; Takami T; Ohya T; Kiyama E; Hayashi T; Nishii H; Miki H; Kobayashi K; Honda K; Ohtake H
J Biosci Bioeng; 2008 Dec; 106(6):568-73. PubMed ID: 19134553
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human interferon-gamma. Differences in glycosylation and proteolytic processing lead to heterogeneity in batch culture.
Curling EM; Hayter PM; Baines AJ; Bull AT; Gull K; Strange PG; Jenkins N
Biochem J; 1990 Dec; 272(2):333-7. PubMed ID: 2125204
[TBL] [Abstract][Full Text] [Related]
17. Comparison of membrane adsorber (MA) based purification schemes for the down-stream processing of recombinant h-AT III.
Reif OW; Freitag R
Bioseparation; 1994 Dec; 4(6):369-81. PubMed ID: 7765681
[TBL] [Abstract][Full Text] [Related]
18. Immobilization of the slime mould Dictyostelium discoideum for the continuous production of recombinant human antithrombin III.
Tiltscher H; Storr M
Appl Microbiol Biotechnol; 1993 Nov; 40(2-3):246-50. PubMed ID: 7764383
[TBL] [Abstract][Full Text] [Related]
19. Serum-free media formulations are cell line-specific and require optimization for microcarrier culture.
Tan KY; Teo KL; Lim JF; Chen AK; Choolani M; Reuveny S; Chan J; Oh SK
Cytotherapy; 2015 Aug; 17(8):1152-65. PubMed ID: 26139547
[TBL] [Abstract][Full Text] [Related]
20. Improved production of recombinant human antithrombin III in Chinese hamster ovary cells by ATF4 overexpression.
Ohya T; Hayashi T; Kiyama E; Nishii H; Miki H; Kobayashi K; Honda K; Omasa T; Ohtake H
Biotechnol Bioeng; 2008 Jun; 100(2):317-24. PubMed ID: 18078289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
